Increased analgesic tolerance to acute morphine in fosB knock-out mice: a gender study

Wojciech Solecki1, Tomasz Krowka, Jakub Kubik

  • 1Department of Molecular Neuropharmacology, Institute of Pharmacology, Polish Academy of Science, 12 Smetna Street, 31-343 Krakow, Poland. wsolecki@if-pan.krakow.pl

Insights

The FosB gene is crucial for developing tolerance to morphine

Area of Science:

  • Neuroscience
  • Pharmacology
  • Genetics

Background:

  • The Fos family of proteins may link morphine's molecular actions to behavioral outcomes like reward, dependence, and tolerance.
  • Understanding the role of specific genes, like fosB, is key to elucidating these complex mechanisms.

Purpose of the Study:

  • To investigate the contribution of the fosB gene to morphine-induced analgesia, hypothermia, and tolerance.
  • To examine potential gender-specific effects of the fosB gene on morphine responses.

Main Methods:

  • Utilized male and female mice genetically engineered to lack the fosB gene (fosB -/-) and compared them to wild-type mice (fosB +/+).
  • Assessed morphine analgesia using the tail-flick test and morphine-induced hypothermia.
  • Evaluated responses in both morphine-naive and morphine-tolerant mice.

Main Results:

  • Mice lacking the fosB gene exhibited enhanced tolerance to morphine-induced analgesia compared to wild-type mice.
  • No significant effects of genotype or gender were observed on tolerance to morphine-induced hypothermia.
  • Female fosB -/- mice showed increased analgesic potency from morphine, suggesting a gender-specific role.

Conclusions:

  • The fosB gene plays a significant role in the development of tolerance to morphine analgesia, but not hypothermia.
  • The absence of FosB proteins influences morphine's analgesic effects, particularly in female mice, highlighting its importance in pain modulation.
  • These findings underscore the specific involvement of the fosB gene in morphine's effects on analgesia versus hypothermia.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...